Dupixent is a brand-name injection that doctors prescribe to treat certain conditions, including atopic dermatitis and asthma. Injection site reactions ... into your thigh or abdomen outside ...

One day after a subcutaneous injection into the left thigh, she developed a mildly pruritic eruption on the right thigh, at the site of a previous injection. There is an erythematous, slightly ...

A preliminary study on popular weight loss drugs finds participants shed more weight on Zepbound than on Novo Nordisk’s ...

Employees at a prominent downtown harm reduction facility are facing layoffs in the wake of Premier Doug Ford’s decision to shutter supervised drug consumption sites, according to their union.

The union representing Toronto Public Health employees says the city has issued layoff notices to all workers at the The Works safe injection site with the site set to close next spring due to ...

Recently, weight loss drugs like Ozempic and Wegovy have gained widespread attention, transforming the landscape of obesity management and weight loss treatments. Initially developed for the treatment ...

The results of the first head-to-head trial of Lilly's dual GLP-1/GIP agonist Zepbound (tirzepatide) and Novo Nordisk's GLP-1 agonist Wegovy (semaglutide) have shown experimentally what has been ...

Shares of Eli Lilly climbed Wednesday after the drugmaker detailed a study showing that its blockbuster weight-loss drug Zepbound helped patients shed more pounds than Wegovy from rival Novo Nordisk.

Weight loss drugs such as Ozempic and Wegovy are increasingly popular among adults, who have flocked to the new medication as an alternative to the traditional — and often ineffective — advice ...

The trial, known as SURMOUNT-5, found that participants using Zepbound lost an average of 20.2% of their body weight, while those on Wegovy lost 13.7%. This marks a 47% difference in weight loss ...

The drug, called amycretin and codenamed NN9487, is a dual agonist that targets both GLP-1 and amylin and is being developed in both oral and subcutaneous injection formulations. The oral form has ...